| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.03.24 | Rubicon Technologies, Inc. Receives Notice of Non-Compliance with NYSE Trading Share Price and Market Capitalization Listing Rules | 420 | Business Wire | NEW YORK--(BUSINESS WIRE)--Rubicon Technologies, Inc. ("Rubicon" or the "Company") (NYSE: RBT), a leading provider of technology solutions for waste, recycling, and fleet operations, today announced... ► Artikel lesen | |
| 22.03.24 | Axonics Stockholders Approve Merger Agreement with Boston Scientific | 263 | Business Wire | IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) announced that its stockholders have voted today to adopt Axonics' merger agreement with Boston Scientific Corporation (NYSE: BSX).... ► Artikel lesen | |
| 22.03.24 | Amen Properties Reports Results for Fourth Quarter of 2023 and Announces Dividend | 146 | Business Wire | DALLAS--(BUSINESS WIRE)--Amen Properties, Inc. (Pink Sheets: AMEN) today announced financial results for its fiscal year ended December 31, 2023. The Company posted revenue of $3.7 million and... ► Artikel lesen | |
| 22.03.24 | Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023 | 270 | Business Wire | SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on harnessing the power of trained... ► Artikel lesen | |
| 22.03.24 | Daiichi Sankyo: CHMP gibt positive Stellungnahmen für Bempedosäure und die Bempedosäure/Ezetimib-Kombinationstablette zur Behandlung von Hypercholesterinämie und zur signifikanten Verringerung kardiovaskulärer Ereignisse ab | 1.139 | Business Wire | Die positiven Stellungnahmen des CHMP beruhen auf den Analysen der Phase-3-Studie CLEAR (Cholesterol Lowering via Bempedoic Acid, an ATP citrate lyase (ACL)-Inhibiting Regimen) Outcomes. 1 ... ► Artikel lesen | |
| 22.03.24 | Kroll Bond Rating Agency, LLC: KBRA Assigns Preliminary Ratings to Roundstone Securities No.2 DAC | 2.760 | Business Wire | KBRA Europe (KBRA) assigns preliminary ratings to six classes of notes issued by Roundstone Securities No.2 DAC (Roundstone 2). The transaction is a static RMBS securitisation backed by seasoned performing... ► Artikel lesen | |
| 22.03.24 | Hamilton Global Opportunities plc Published Its 2023 Full-Year Financial Results and Activity Report | 525 | Business Wire | Highlights for 2023: Focus on portfolio management Additional investment in Gauzy Ltd a world leader in smart glass and ADAS technologies in March 2023 Financial elements:... ► Artikel lesen | |
| 22.03.24 | AM Best Affirms Credit Ratings of CICA-RE | 285 | Business Wire | AM Best has affirmed the Financial Strength Rating of B+ (Good) and the Long-Term Issuer Credit Rating of "bbb-" (Good) of Compagnie Commune de Réassurance des Etats Membres de la CIMA (CICA-RE)... ► Artikel lesen | |
| 22.03.24 | Curaleaf International kommentiert die schnelle Verabschiedung des deutschen Bundes-Cannabisgesetzes | 522 | Business Wire | Heute wurde bekannt gegeben, dass das Cannabisgesetz der deutschen Bundesregierung, auch bekannt als Säule 1, erfolgreich und ohne Verzögerung vorangekommen ist. Nach dem positiven Ausgang der Abstimmung... ► Artikel lesen | |
| 22.03.24 | BM3EAC Corp. Vereinbarung mit Arkon Energy | 374 | Business Wire | BM3EAC Corp. (das "Unternehmen"), eine nach dem Recht der Kaimaninseln gegründete und an der Euronext Amsterdam, dem von der Euronext Amsterdam N.V. betriebenen geregelten Markt, notierte Mantelgesellschaft... ► Artikel lesen | |
| 22.03.24 | Research and Markets: 2024 Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report Featuring IQVIA, ICON, Parexel, Fortrea (formerly Labcorp), PPD/Thermo Fisher, and Syneos Health - ResearchAndMarkets.com | 790 | Business Wire | The "2024 Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report" has been added to ResearchAndMarkets.com's offering.
The biopharmaceutical clinical development landscape... ► Artikel lesen | |
| 22.03.24 | GenSight Biologics Reports Full Year 2023 Consolidated Financial Results | 441 | Business Wire | PARIS--(BUSINESS WIRE)--Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative... ► Artikel lesen | |
| 22.03.24 | Veolia Environnement: Availability of the 2023 Universal Registration Document / Annual Financial Report (French version) | 509 | Business Wire | Regulatory News:
Veolia Environnement (Paris:VIE) announces that the French version of the 2023 Universal Registration Document ("URD") was filed on March 21,2024 with the French Financial Markets... ► Artikel lesen | |
| 22.03.24 | GenSight Biologics S.A.: GenSight Biologics Reports Full Year 2023 Consolidated Financial Results | 372 | Business Wire | Efforts to reduce operational expenses confirming the cash runway until the end of April 2024
Mobilization of resources aimed at releasing the batch of LUMEVOQ® Drug Product expected in... ► Artikel lesen | |
| 22.03.24 | Gilead Sciences Announces Completion of Acquisition of CymaBay | 212 | Business Wire | FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire CymaBay Therapeutics, Inc. (Nasdaq:... ► Artikel lesen | |
| 22.03.24 | American Realty Investors, Inc. reports Earnings for Quarter Ended December 31, 2024 | 260 | Business Wire | DALLAS--(BUSINESS WIRE)--American Realty Investors, Inc. (NYSE:ARL) is reporting its results of operations for the quarter ended December 31, 2023. For the three months ended December 31, 2023... ► Artikel lesen | |
| 22.03.24 | Transcontinental Realty Investors, Inc. reports Earnings for Quarter Ended December 31, 2023 | 205 | Business Wire | DALLAS--(BUSINESS WIRE)--Transcontinental Realty Investors, Inc. (NYSE:TCI) is reporting its results of operations for the quarter ended December 31, 2023. For the three months ended December 31... ► Artikel lesen | |
| 22.03.24 | Income Opportunity Realty Investors, Inc. Reports Earnings for Quarter Ended December 31, 2023 | 197 | Business Wire | DALLAS--(BUSINESS WIRE)--Income Opportunity Realty Investors, Inc. (NYSE American:IOR) is reporting its results of operations for the quarter ended December 31, 2023. For the three months ended... ► Artikel lesen | |
| 22.03.24 | CARMAT Announces a Final Agreement With All Its Financial Creditors on New Repayment Terms for Its Bank Loans | 429 | Business Wire | Final maturity of all bank loans extended by at least 2 years Equitization of the loan contracted with the EIB to reduce its repayment in cash and optimize the Company's cash position
Regulatory... ► Artikel lesen | |
| 22.03.24 | University of Phoenix Leadership Join Proceedings of 2024 Mediterranean Region Counseling Association Conference | 541 | Business Wire | College of Social and Behavioral Sciences Associate Dean, Sheila Babendir, Ed.D., LPC, and Program Chair, Christine Karper, Ph.D., LMHC present on counselor education for a global society University... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| TESLA | 3.794 |
| NVIDIA | 3.190 |
| RHEINMETALL | 2.043 |
| RENK GROUP | 1.777 |
| THYSSENKRUPP | 1.678 |
| STEYR MOTORS | 1.616 |
| BYD | 1.574 |
| BAYER | 1.561 |
| NEL | 1.452 |
| DEUTZ | 1.442 |
| TUI | 1.400 |
| VOLKSWAGEN | 1.229 |
| EVOTEC | 1.146 |
| NOVO NORDISK | 1.129 |
| MERCEDES-BENZ | 1.009 |
| XIAOMI | 943 |
| AMAZON | 926 |
| PUMA | 890 |
| PORSCHE AG | 870 |
| BASF | 858 |
| COMMERZBANK | 786 |
| DEUTSCHE BANK | 784 |
| NORDEX | 772 |
| AIXTRON SE | 728 |
| VONOVIA | 638 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
